Viewing Study NCT03535961


Ignite Creation Date: 2025-12-24 @ 12:34 PM
Ignite Modification Date: 2026-03-20 @ 2:57 AM
Study NCT ID: NCT03535961
Status: COMPLETED
Last Update Posted: 2020-12-02
First Post: 2017-09-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
Sponsor: Chinese Academy of Medical Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords: